Trial Profile
Immunologic Responses to a Live Attenuated Oral Cholera Vaccine
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Jun 2023
Price :
$35
*
At a glance
- Drugs PXVX 0200 (Primary)
- Indications Cholera
- Focus Pharmacodynamics
- 01 Jun 2023 Status changed from suspended to recruiting.
- 29 Aug 2022 Planned End Date changed from 30 Jun 2023 to 30 Jun 2025.
- 29 Aug 2022 Planned primary completion date changed from 30 Jul 2022 to 30 Jun 2024.